Skip to content

Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary Hypertension

The Impact of Hypoxia on Patients With Precapillary Pulmonary Hypertension and Treatment of Adverse Effects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05089487
Enrollment
28
Registered
2021-10-22
Start date
2021-10-18
Completion date
2022-04-15
Last updated
2022-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Altitude Pulmonary Hypertension, Sleep

Brief summary

The impact of hypoxia at 2500m of high altitude on sleep in patients with precapillary pulmonary hypertension

Interventions

PROCEDURENocturnal rest (sleep study)

Proportion of patients free of severe hypoxemia without oxygen therapy during nocturnal rest .

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent as documented by signature (Appendix Informed Consent Form) * PH class I (PAH) or IV (CTEPH) diagnosed according to guidelines: mean pulmonary artery pressure \>20 mmHg, pulmonary vascular resistance ≥3 wood units, pulmonary arterial wedge pressure ≤15 mmHg during baseline measures at the diagnostic right-heart catheterization

Exclusion criteria

* resting partial pressure of oxygen \<8 kilopascal at Zurich at 490 m low altitude * exposure to an altitude \>1000 m for ≥3 nights during the last 2 weeks before the study * inability to follow the procedures of the study * other clinically significant concomitant end-stage disease (e.g., renal failure, hepatic dysfunction)

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients free of severe hypoxemia30 hoursProportion of patients free of severe hypoxemia (defined as oxygenation (SpO2)\<80% for \>30 min) without oxygen therapy during nocturnal rest at 2500 m vs. 490 m

Secondary

MeasureTime frameDescription
Oxygen desaturation index30 hoursDifference in oxygen desaturation index sleeping at 2500 m high altitude vs 490 m low altitude
Periodic breathing30 hoursDifference in time spent with periodic breathing in patients sleeping at 2500 m of high altitude vs 490 m low altitude
Nocturnal transcutaneous carbon dioxide tension30 hoursDifference in nocturnal transcutaneous carbon dioxide tension in patients sleeping at 2500 m of high altitude vs 490 m low altitude
Visual Analogue Scale30 hoursSubjective sleep quality Visual Analogue Scale score 2500 m high altitude vs 490 m low altitude
Time spent awake during the night30 hoursSubjective time spent awake during the night high altitude vs 490 m low altitude
Cerebral tissue deoxygenation30 hoursProportion of patients free of severe cerebral tissue deoxygenation (drop in cerebral tissue oxygen saturation \>5%) without oxygen therapy during a night at 2500 vs. 490 m
Nocturnal oxygenation30 hoursDifference in mean nocturnal oxygenation (SpO2) 2500 m of high altitude vs 490 m low altitude
Cerebral tissue oxygen saturation during sleep without oxygen30 hoursDifference in cerebral tissue oxygen saturation during sleep in patients with precapillary pulmonary hypertension at 2500m of high altitude without supplemental oxygen
Cerebral tissue oxygen saturation during sleep with oxygen30 hoursDifference in cerebral tissue oxygen saturation during sleep in patients with precapillary pulmonary hypertension at 2500m of high altitude with supplemental oxygen
Cerebral oxygen desaturation index without oxygen30 hoursDifference in the cerebral oxygen desaturation index in patients with precapillary pulmonary hypertension at 2500m of high altitude without supplemental oxygen vs. low altitude
Cerebral oxygen desaturation index with oxygen30 hoursDifference in the cerebral oxygen desaturation index in patients with precapillary pulmonary hypertension at 2500m of high altitude under supplemental oxygen.
Cerebral tissue oxygen saturation between different sleep stages30 hoursChanges in the cerebral tissue oxygen saturation between different sleep stages at 2500 m compared to low altitude.
Cerebral tissue oxygen saturation awake30 hoursDifference in cerebral tissue oxygen saturation awake in patients with precapillary pulmonary hypertension at 2500m of high altitude without supplemental oxygen vs. low altitude

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026